Atul Arvindbhai Vasani has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
VAISHALI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Atul Arvindbhai Vasani, Promoter and Chairman-cum-Managing Director of Vaishali Pharma Limited, has submitted the annual declaration under Regulation 31(4) of SEBI's Takeover Regulations. The filing confirms that members of the promoter and promoter group, along with persons acting in concert, have not created any encumbrance (pledge, lien, or similar charge) directly or indirectly on the company's shares during the financial year ended 31st March 2025. This is a mandatory yearly disclosure required from promoters regarding pledging activity.
This is a routine, neutral-to-slightly-positive filing for shareholders, as it reassures investors that promoters have not pledged their shareholding during FY25, indicating no immediate liquidity stress at the promoter level.